Prognostic significance was also calculated and revealed that the sdLDL and resistin level could be the indicator to predict cardiometabolic complications (e.g., insulin resistance, dyslipidemia and hypertension) at the cutoff value of 18.55 mg/dl for sdLDL and 750pg/mL for resistin which could help to minimize the risk of developing related comorbidities. Here, RETN is linked to metabolic syndrome.